Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of MKT-N2 vs Singulair in Healthy Korean Males
NCT02029313Phase 1Completed
- Sponsor
- PharmaKing
- Start
- Nov 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in asthma and allergic rhinitis (AR) (2 arms), sponsored by PharmaKing. Primary endpoint: Number of participants with Adverse event at 1 day. Started Nov 2013; status: completed.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NCT02029313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02029313.